AbbVie has announced that it will launch its ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) in the United ...
Basel: Novartis has announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of ...
KALA BIO, Inc. a clinical-stage biopharmaceutical company focused on eye diseases, announced that its CHASE Phase 2b trial ...
Hyderabad: Private hospitals in the state have taken their fight against the new bio-medical waste fee system to the ...
Cambridge: AstraZeneca plans to harmonise its share listing structure to deliver a global listing for global investors in a ...
Every so often, we wake up with a stiff neck. It may be the way we slept, or too many hours hunched over a screen. For most, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback